SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 11,319.67 |
| Enterprise Value ($M) | 10,811.97 |
| Book Value ($M) | 5,984.80 |
| Book Value / Share | 134.89 |
| Price / Book | 1.89 |
| NCAV ($M) | 2,368.80 |
| NCAV / Share | 53.39 |
| Price / NCAV | 4.78 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.16 |
| Return on Assets (ROA) | 0.17 |
| Return on Equity (ROE) | 0.21 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.28 |
| Current Ratio | 4.41 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 3,551.00 |
| Assets | 7,167.00 |
| Liabilities | 1,182.20 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 2,327.50 |
| Operating Income | 1,186.00 |
| Net Income | 984.80 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 978.00 |
| Cash from Investing | -719.60 |
| Cash from Financing | -11.90 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Rothblatt Martine A | 7.80 | -0.49 | |
| 13G/A | Avoro Capital Advisors LLC | 6.10 | -0.21 | |
| 13G/A | Renaissance Technologies Llc | 4.62 | -7.43 | |
| 13G/A | Vanguard Group Inc | 9.95 | 4.31 | |
| 13G/A | Fmr Llc | 4.94 | -10.27 | |
| 13G/A | Wellington Management Group Llp | 8.07 | -19.08 | |
| 13G/A | BlackRock Inc. | 11.30 | 12.01 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 126,085 | 610,856 | 20.64 | |
| 249,623 | 1,117,695 | 22.33 | |
| 103,410 | 478,320 | 21.62 | |
| 76,568 | 284,892 | 26.88 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TXMD – TherapeuticsMD, Inc. | TYRA – Tyra Biosciences, Inc. |
| UBX – Unity Biotechnology, Inc. | VERV – Verve Therapeutics, Inc. |
| VIGL – Vigil Neuroscience, Inc. |
Financial data and stock pages provided by
Fintel.io